Duyuru • Jul 24
Jamieson Wellness Inc. to Report Q2, 2026 Results on Aug 06, 2026 Jamieson Wellness Inc. announced that they will report Q2, 2026 results After-Market on Aug 06, 2026 Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €25.60, the stock trades at a trailing P/E ratio of 23.6x. Average forward P/E is 17x in the Personal Products industry in Europe. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €35.71 per share. Declared Dividend • May 20
First quarter dividend of CA$0.23 announced Shareholders will receive a dividend of CA$0.23. Ex-date: 1st June 2026 Payment date: 15th June 2026 Dividend yield will be 3.1%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by earnings (1% earnings payout ratio) but not covered by cash flows (123% cash payout ratio). The dividend has increased by an average of 12% per year over the past 9 years and payments have been stable during that time. Earnings per share has grown by 12% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Duyuru • Apr 24
Jamieson Wellness Inc. to Report Q1, 2026 Results on May 07, 2026 Jamieson Wellness Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026 Duyuru • Mar 09
Jamieson Wellness Inc., Annual General Meeting, May 19, 2026 Jamieson Wellness Inc., Annual General Meeting, May 19, 2026. Duyuru • Feb 13
Jamieson Wellness Inc. to Report Q4, 2025 Results on Feb 26, 2026 Jamieson Wellness Inc. announced that they will report Q4, 2025 results After-Market on Feb 26, 2026 Duyuru • Oct 24
Jamieson Wellness Inc. to Report Q3, 2025 Results on Nov 06, 2025 Jamieson Wellness Inc. announced that they will report Q3, 2025 results at 4:00 PM, Eastern Standard Time on Nov 06, 2025 Duyuru • Oct 22
Jamieson Wellness Inc. Appoints Gayle Tait to the Board of Directors, Effective October 27, 2025 Jamieson Wellness Inc. announced the appointment of Gayle Tait to the Company’s Board of Directors. Ms. Tait’s executive experience in both public and private companies spans over 25 years, including roles at Google Play, L’Oréal UK consumer products division, and most recently as CEO of Trove, a venture-backed circular economy business. She currently serves on the board of e.l.f. Beauty, where she has helped guide the company through a period of hypergrowth, international expansion and operational scale. During her tenure, e.l.f has become a leader in community-based business, pioneering in non-traditional digital channels to connect with the consumer and bring the values of the company to life. She also contributed to strategy and oversight during e.l.f’s brand acquisitions of Naturium Skin and rhode Beauty. Ms. Tait’s appointment to the Board is effective October 27, 2025, at which time she will also begin serving on the Company’s Governance, Compensation and Nominating Committee. Duyuru • Jul 25
Jamieson Wellness Inc. to Report Q2, 2025 Results on Aug 07, 2025 Jamieson Wellness Inc. announced that they will report Q2, 2025 results at 4:00 PM, Eastern Standard Time on Aug 07, 2025 Duyuru • Apr 25
Jamieson Wellness Inc. to Report Q1, 2025 Results on May 08, 2025 Jamieson Wellness Inc. announced that they will report Q1, 2025 results at 4:00 PM, US Eastern Standard Time on May 08, 2025 Duyuru • Mar 03
Jamieson Wellness Inc., Annual General Meeting, May 27, 2025 Jamieson Wellness Inc., Annual General Meeting, May 27, 2025. Duyuru • Feb 14
Jamieson Wellness Inc. to Report Q4, 2024 Results on Feb 27, 2025 Jamieson Wellness Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025 Duyuru • Nov 15
Jamieson Wellness Inc. Appoints of Diane Nyisztor to its Board of Directors, as Member of Governance, Compensation, and Nominating Committee, Effective January 1, 2025 Jamieson Wellness Inc. announced the appointment of Diane Nyisztor to the Company’s Board of Directors, effective January 1, 2025. Ms. Nyisztor is a Chartered Professional Accountant and former senior executive with more than 30 years of experience in global human resources, compensation advisory, corporate governance, and expatriate tax. She served as Senior Vice President and Chief Human Resources Officer at Cogeco Inc. between 2014 and 2021 and was Partner, International Executive Services at KPMG Canada LLP from 2013 to 2014. Prior to that, Ms. Nyisztor held several progressively senior leadership positions in human resources at AtkinsRéalis (formerly SNC-Lavalin Group Inc.). Ms. Nyisztor is also an experienced board member. Since 2016, she has served as a Corporate Director and member of the Corporate Governance and Human Resources committee for Saputo Inc. She also serves on the board of the YMCAs of Québec, where she is Chair of the Human Resources Committee. Ms. Nyisztor’s appointment to the Jamieson Wellness Board of Directors is effective as of January 1, 2025. At that time, she will also begin serving as a member of the Company’s Governance, Compensation, and Nominating Committee. Reported Earnings • Nov 09
Third quarter 2024 earnings released: EPS: CA$0.25 (vs CA$0.20 in 3Q 2023) Third quarter 2024 results: EPS: CA$0.25 (up from CA$0.20 in 3Q 2023). Revenue: CA$176.2m (up 16% from 3Q 2023). Net income: CA$10.6m (up 28% from 3Q 2023). Profit margin: 6.0% (up from 5.4% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Duyuru • Oct 25
Jamieson Wellness Inc. to Report Q3, 2024 Results on Nov 07, 2024 Jamieson Wellness Inc. announced that they will report Q3, 2024 results After-Market on Nov 07, 2024 Declared Dividend • Aug 19
Second quarter dividend of CA$0.21 announced Shareholders will receive a dividend of CA$0.21. Ex-date: 30th August 2024 Payment date: 13th September 2024 Dividend yield will be 2.9%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by earnings (88% earnings payout ratio) but not covered by cash flows (dividend approximately 9x free cash flows). The dividend has increased by an average of 15% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 49% over the next year, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 09
Second quarter 2024 earnings released: EPS: CA$0.21 (vs CA$0.20 in 2Q 2023) Second quarter 2024 results: EPS: CA$0.21 (up from CA$0.20 in 2Q 2023). Revenue: CA$184.8m (up 10% from 2Q 2023). Net income: CA$8.65m (up 5.7% from 2Q 2023). Profit margin: 4.7% (down from 4.9% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Duyuru • Jul 26
Jamieson Wellness Inc. to Report Q2, 2024 Results on Aug 08, 2024 Jamieson Wellness Inc. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024 Declared Dividend • May 20
First quarter dividend of CA$0.19 announced Shareholders will receive a dividend of CA$0.19. Ex-date: 31st May 2024 Payment date: 14th June 2024 Dividend yield will be 3.3%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by earnings (65% earnings payout ratio) but not covered by cash flows (391% cash payout ratio). The dividend has increased by an average of 13% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 44% over the next year, which should provide support to the dividend and adequate earnings cover. New Risk • May 10
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.5% Last year net profit margin: 8.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (3.8% operating cash flow to total debt). Minor Risks Dividend is not well covered by cash flows (391% cash payout ratio). Profit margins are more than 30% lower than last year (5.5% net profit margin). Reported Earnings • May 10
First quarter 2024 earnings released: CA$0.099 loss per share (vs CA$0.17 profit in 1Q 2023) First quarter 2024 results: CA$0.099 loss per share (down from CA$0.17 profit in 1Q 2023). Revenue: CA$128.0m (down 6.4% from 1Q 2023). Net loss: CA$4.11m (down 158% from profit in 1Q 2023). Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. Duyuru • Apr 28
Jamieson Wellness Inc. to Report Q1, 2024 Results on May 09, 2024 Jamieson Wellness Inc. announced that they will report Q1, 2024 results After-Market on May 09, 2024 Reported Earnings • Mar 14
Full year 2023 earnings released: EPS: CA$1.14 (vs CA$1.29 in FY 2022) Full year 2023 results: EPS: CA$1.14 (down from CA$1.29 in FY 2022). Revenue: CA$676.2m (up 24% from FY 2022). Net income: CA$47.9m (down 9.3% from FY 2022). Profit margin: 7.1% (down from 9.6% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Duyuru • Mar 14
Jamieson Wellness Inc. Provides Consolidated Earnings Guidance for the Fiscal 2024 Jamieson Wellness Inc. provided consolidated earnings guidance for the fiscal 2024. For the year, consolidated revenue of between $720.0 million to $760.0 million, representing growth of 6.5% to 12.5%. Duyuru • Mar 07
Jamieson Wellness Inc. to Report Q4, 2023 Results on Mar 13, 2024 Jamieson Wellness Inc. announced that they will report Q4, 2023 results After-Market on Mar 13, 2024 Declared Dividend • Feb 28
Third quarter dividend of CA$0.19 announced Shareholders will receive a dividend of CA$0.19. Ex-date: 29th February 2024 Payment date: 15th March 2024 Dividend yield will be 2.7%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by both earnings (66% earnings payout ratio) and cash flows (85% cash payout ratio). The dividend has increased by an average of 13% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 35% over the next year, which should provide support to the dividend and adequate earnings cover. Duyuru • Feb 24
Jamieson Wellness Inc., Annual General Meeting, May 23, 2024 Jamieson Wellness Inc., Annual General Meeting, May 23, 2024. Duyuru • Feb 23
Jamieson Wellness Inc. Declares Fourth Quarter 2023 Dividend, Payable on March 15, 2024 Jamieson Wellness Inc. announced that the board of directors of the Company has declared a cash dividend for the fourth quarter of 2023 of $0.19 per common share, or approximately $8.0 million in the aggregate. The dividend will be paid on March 15, 2024 to all common shareholders of record at the close of business on March 1, 2024. Upcoming Dividend • Nov 23
Upcoming dividend of CA$0.19 per share at 2.6% yield Eligible shareholders must have bought the stock before 30 November 2023. Payment date: 15 December 2023. Payout ratio is a comfortable 66% and the cash payout ratio is 79%. Trailing yield: 2.6%. Lower than top quartile of German dividend payers (5.0%). Higher than average of industry peers (1.8%). Valuation Update With 7 Day Price Move • Nov 09
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to €18.40, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 21x in the Personal Products industry in Europe. Total loss to shareholders of 18% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €23.97 per share. New Risk • Nov 06
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 20% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.0% net profit margin). Duyuru • Nov 03
Jamieson Wellness Inc. Revises Consolidated Earnings Guidance for the Year 2023 Jamieson Wellness Inc. revised consolidated earnings guidance for the year 2023. The company expected revenue to range between $680.0 and $690.0 million (+24.0% to +26.0%) from a previous range of +22.0% to +26.0%. Reported Earnings • Nov 03
Third quarter 2023 earnings released: EPS: CA$0.20 (vs CA$0.26 in 3Q 2022) Third quarter 2023 results: EPS: CA$0.20 (down from CA$0.26 in 3Q 2022). Revenue: CA$151.5m (up 9.1% from 3Q 2022). Net income: CA$8.22m (down 24% from 3Q 2022). Profit margin: 5.4% (down from 7.8% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Duyuru • Oct 18
Jamieson Wellness Inc. to Report Q3, 2023 Results on Nov 02, 2023 Jamieson Wellness Inc. announced that they will report Q3, 2023 results After-Market on Nov 02, 2023 Upcoming Dividend • Aug 24
Upcoming dividend of CA$0.19 per share at 3.0% yield Eligible shareholders must have bought the stock before 31 August 2023. Payment date: 15 September 2023. Payout ratio is a comfortable 61% but the company is paying out more than the cash it is generating. Trailing yield: 3.0%. Lower than top quartile of German dividend payers (4.9%). Higher than average of industry peers (2.0%). Recent Insider Transactions • Aug 13
Independent Chair recently bought €202k worth of stock On the 9th of August, Timothy Penner bought around 11k shares on-market at roughly €18.38 per share. This transaction increased Timothy's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Timothy's only on-market trade for the last 12 months. New Risk • Aug 07
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 20% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (9.2% operating cash flow to total debt). Minor Risks Dividend is not well covered by cash flows (101% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.6% net profit margin). Buying Opportunity • Aug 06
Now 27% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be €25.52, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 10%. Reported Earnings • Aug 05
Second quarter 2023 earnings released: EPS: CA$0.20 (vs CA$0.25 in 2Q 2022) Second quarter 2023 results: EPS: CA$0.20 (down from CA$0.25 in 2Q 2022). Revenue: CA$167.6m (up 50% from 2Q 2022). Net income: CA$8.19m (down 19% from 2Q 2022). Profit margin: 4.9% (down from 9.0% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.1% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Duyuru • Jul 14
Jamieson Wellness Inc. to Report Q2, 2023 Results on Aug 03, 2023 Jamieson Wellness Inc. announced that they will report Q2, 2023 results After-Market on Aug 03, 2023 Duyuru • Jun 30
Jamieson Wellness Inc. Appoints François Vimard as New Board Director, Effective from July 1, 2023 Jamieson Wellness Inc. announced the appointment of François Vimard to the Company’s Board of Directors. Mr. Vimard is a Chartered Professional Accountant with over 30 years of grocery retail experience, including 22 years at Empire Company. During his tenure at Empire, Mr. Vimard served as Chief Financial Officer from 2007 to 2014, and was appointed interim President and Chief Executive Officer in 2016, a position which he held until his retirement from the company in 2017. Mr. Vimard is a seasoned board member who currently serves as chair of the Board of Kruger Products Inc. He also serves on the boards of GS1 Canada, a not-for-profit company that manages global barcode standards, and Andrew Peller LTD. He previously served on the board for Market GoodFood (FOOD). Mr. Vimard’s appointment to the Jamieson Wellness Board of Directors is effective as of July 1, 2023. He will also serve as a member of the Company’s Audit Committee. Upcoming Dividend • May 24
Upcoming dividend of CA$0.17 per share at 2.2% yield Eligible shareholders must have bought the stock before 31 May 2023. Payment date: 15 June 2023. Payout ratio is a comfortable 56% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (1.9%). Duyuru • May 17
Jamieson Wellness Inc. announced that it has received CAD 149 million in funding from DCP Investments On May 16, 2023, Jamieson Wellness Inc. closed the transaction. Reported Earnings • May 07
First quarter 2023 earnings released: EPS: CA$0.17 (vs CA$0.24 in 1Q 2022) First quarter 2023 results: EPS: CA$0.17 (down from CA$0.24 in 1Q 2022). Revenue: CA$136.7m (up 32% from 1Q 2022). Net income: CA$7.07m (down 28% from 1Q 2022). Profit margin: 5.2% (down from 9.4% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.1% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Buying Opportunity • May 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be €27.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 17%. Buying Opportunity • Apr 06
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 12%. The fair value is estimated to be €27.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 17%. Recent Insider Transactions • Mar 26
President recently bought €102k worth of stock On the 21st of March, Michael Pilato bought around 5k shares on-market at roughly €20.30 per share. This transaction amounted to 18% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months. Reported Earnings • Feb 26
Full year 2022 earnings released: EPS: CA$1.29 (vs CA$1.30 in FY 2021) Full year 2022 results: EPS: CA$1.29. Revenue: CA$547.4m (up 21% from FY 2021). Net income: CA$52.8m (up 1.4% from FY 2021). Profit margin: 9.6% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the Personal Products industry in Europe. Buying Opportunity • Feb 25
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 4.1%. The fair value is estimated to be €29.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 20%. Duyuru • Feb 08
Jamieson Wellness Inc. to Report Q4, 2022 Results on Feb 23, 2023 Jamieson Wellness Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 23, 2023 Upcoming Dividend • Nov 23
Upcoming dividend of CA$0.17 per share Eligible shareholders must have bought the stock before 30 November 2022. Payment date: 15 December 2022. Payout ratio is a comfortable 51% and the cash payout ratio is 94%. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.9%). In line with average of industry peers (2.1%). Reported Earnings • Nov 05
Third quarter 2022 earnings released: EPS: CA$0.26 (vs CA$0.35 in 3Q 2021) Third quarter 2022 results: EPS: CA$0.26 (down from CA$0.35 in 3Q 2021). Revenue: CA$138.9m (up 24% from 3Q 2021). Net income: CA$10.9m (down 24% from 3Q 2021). Profit margin: 7.8% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Nov 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 13%. The fair value is estimated to be €30.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 20%. Buying Opportunity • Sep 17
Now 21% undervalued Over the last 90 days, the stock is up 6.3%. The fair value is estimated to be €34.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 21%. Buying Opportunity • Aug 27
Now 21% undervalued Over the last 90 days, the stock is up 9.5%. The fair value is estimated to be €34.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 21%. Upcoming Dividend • Aug 23
Upcoming dividend of CA$0.17 per share Eligible shareholders must have bought the stock before 30 August 2022. Payment date: 15 September 2022. Payout ratio is a comfortable 46% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.6%). In line with average of industry peers (2.1%). Reported Earnings • Aug 06
Second quarter 2022 earnings released: EPS: CA$0.25 (vs CA$0.29 in 2Q 2021) Second quarter 2022 results: EPS: CA$0.25 (down from CA$0.29 in 2Q 2021). Revenue: CA$112.0m (up 1.3% from 2Q 2021). Net income: CA$10.1m (down 12% from 2Q 2021). Profit margin: 9.0% (down from 10% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 35%, compared to a 7.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 23% per year. Reported Earnings • May 07
First quarter 2022 earnings released: EPS: CA$0.24 (vs CA$0.15 in 1Q 2021) First quarter 2022 results: EPS: CA$0.24 (up from CA$0.15 in 1Q 2021). Revenue: CA$103.7m (up 5.5% from 1Q 2021). Net income: CA$9.74m (up 59% from 1Q 2021). Profit margin: 9.4% (up from 6.2% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 8.1%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 24% per year. Duyuru • Apr 20
Jamieson Wellness Inc. to Report Q1, 2022 Results on May 05, 2022 Jamieson Wellness Inc. announced that they will report Q1, 2022 results After-Market on May 05, 2022 Reported Earnings • Feb 26
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: CA$1.30 (up from CA$1.05 in FY 2020). Revenue: CA$451.0m (up 12% from FY 2020). Net income: CA$52.1m (up 25% from FY 2020). Profit margin: 12% (up from 10% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.1%. Over the next year, revenue is forecast to grow 8.0%, compared to a 8.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year whereas the company’s share price has increased by 21% per year. Duyuru • Feb 26
Jamieson Wellness Inc., Annual General Meeting, May 24, 2022 Jamieson Wellness Inc., Annual General Meeting, May 24, 2022. Duyuru • Feb 09
Jamieson Wellness Inc. to Report Q4, 2021 Results on Feb 24, 2022 Jamieson Wellness Inc. announced that they will report Q4, 2021 results After-Market on Feb 24, 2022 Upcoming Dividend • Nov 23
Upcoming dividend of CA$0.15 per share Eligible shareholders must have bought the stock before 30 November 2021. Payment date: 15 December 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (1.8%). Recent Insider Transactions • Nov 13
President recently sold €131k worth of stock On the 9th of November, Michael Pilato sold around 5k shares on-market at roughly €27.15 per share. This was the largest sale by an insider in the last 3 months. Michael has been a seller over the last 12 months, reducing personal holdings by €107k. Reported Earnings • Nov 06
Third quarter 2021 earnings released: EPS CA$0.35 (vs CA$0.31 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CA$112.4m (up 6.4% from 3Q 2020). Net income: CA$14.3m (up 18% from 3Q 2020). Profit margin: 13% (up from 12% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Aug 23
Upcoming dividend of CA$0.15 per share Eligible shareholders must have bought the stock before 30 August 2021. Payment date: 15 September 2021. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (3.1%). In line with average of industry peers (1.8%). Reported Earnings • Aug 08
Second quarter 2021 earnings released: EPS CA$0.29 (vs CA$0.15 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CA$110.6m (up 19% from 2Q 2020). Net income: CA$11.5m (up 90% from 2Q 2020). Profit margin: 10% (up from 6.5% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Duyuru • Aug 08
Jamieson Wellness Inc. Revises Earnings Guidance for the Full Year 2021 Jamieson Wellness Inc. revised earnings guidance for the full year 2021. The company is increasing its outlook for fiscal 2021 and anticipates revenue in a range of $435.0 million to $445.0 million, compared with $421.0 to $438.0 million previously, which represents annual growth of 7.8% to 10.2%. Duyuru • Aug 06
Jamieson Vitamins Launches Limited Edition ‘Health Made Tasty’ Boxes with 100% of Proceeds Going to Feed Tomorrow Jamieson Vitamins is launching limited edition Health Made Tasty boxes filled with items valued at over $200. Following the success of their Spin the Wheel virtual game, which gave away these boxes to select winners, Jamieson will launch flash sales of the Health Made Tasty boxes over a two-week period. Filled with items valued at over $200, Canadians can purchase one for just $50. All sales will go directly to Feed Tomorrow, an organization whose mission is to raise awareness of the critical importance of child and youth nutrition programs as they relate to the issues of health, agriculture and the economy. Valued at over $200, the Health Made Tasty Boxes are filled with Jamieson’s Fun Formats collection, which includes: Vitamin C Chewables, Multivitamin Gummies, Vitamin D3 Gummies, Melatonin Sleep Spray, Turmeric Gummies and Energy & Adaptogen Booster Powder. Other goodies include products from Midnight Paloma, Da Bomb Bath Co., Consonant Skincare, LilySilk, and Lululemon -- plus a premium mystery item. Upcoming Dividend • May 21
Upcoming dividend of CA$0.13 per share Eligible shareholders must have bought the stock before 28 May 2021. Payment date: 14 June 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (2.0%). Reported Earnings • May 07
First quarter 2021 earnings released: EPS CA$0.15 (vs CA$0.20 in 1Q 2020) The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2021 results: Revenue: CA$98.3m (up 16% from 1Q 2020). Net income: CA$6.14m (down 23% from 1Q 2020). Profit margin: 6.2% (down from 9.5% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Mar 16
New 90-day high: €25.00 The company is up 14% from a price of €22.00 on 16 December 2020. Outperformed the German market which is up 9.0% over the last 90 days. Exceeded the Personal Products industry, which is flat over the same period. Simply Wall St's valuation model estimates the intrinsic value at €39.48 per share. 
